As of 2026-10-05, the Relative Valuation of Beam Therapeutics Inc (BEAM) is (25.49) USD. This relative valuation is based on P/E multiples. With the latest stock price at 24.50 USD, the upside of Beam Therapeutics Inc based on Relative Valuation is -204.0%.
The range of the Relative Valuation is (24.16) - (24.74) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 29.1x - 38.9x | 34.0x |
| Forward P/E multiples | 25.0x - 29.8x | 27.4x |
| Fair Price | (24.16) - (24.74) | (25.49) |
| Upside | -198.6% - -201.0% | -204.0% |
| Date | P/E |
| 2026-10-02 | -29.51 |
| 2026-10-01 | -29.37 |
| 2026-09-30 | -29.45 |
| 2026-09-29 | -29.53 |
| 2026-09-28 | -29.18 |
| 2026-09-25 | -29.23 |
| 2026-09-24 | -29.70 |
| 2026-09-23 | -29.35 |
| 2026-09-22 | -31.23 |
| 2026-09-21 | -30.42 |
| 2026-09-18 | -30.05 |
| 2026-09-17 | -29.71 |
| 2026-09-16 | -27.82 |
| 2026-09-15 | -27.96 |
| 2026-09-14 | -29.05 |
| 2026-09-11 | -28.89 |
| 2026-09-10 | -29.35 |
| 2026-09-09 | -30.32 |
| 2026-09-08 | -32.31 |
| 2026-09-04 | -35.72 |
| 2026-09-03 | -35.48 |
| 2026-09-02 | -35.27 |
| 2026-09-01 | -34.95 |
| 2026-08-31 | -35.44 |
| 2026-08-28 | -35.31 |
| 2026-08-27 | -36.71 |
| 2026-08-26 | -36.36 |
| 2026-08-25 | -37.37 |
| 2026-08-24 | -34.12 |
| 2026-08-21 | -35.84 |
| 2026-08-20 | -34.19 |
| 2026-08-19 | -35.01 |
| 2026-08-18 | -32.00 |
| 2026-08-17 | -32.64 |
| 2026-08-14 | -32.22 |
| 2026-08-13 | -31.93 |
| 2026-08-12 | -32.17 |
| 2026-08-11 | -32.34 |
| 2026-08-10 | -32.85 |
| 2026-08-07 | -33.09 |
| 2026-08-06 | -32.82 |
| 2026-08-05 | -32.60 |
| 2026-08-04 | -34.14 |
| 2026-08-03 | -31.20 |
| 2026-07-31 | -30.73 |
| 2026-07-30 | -31.90 |
| 2026-07-29 | -31.34 |
| 2026-07-28 | -31.66 |
| 2026-07-27 | -30.19 |
| 2026-07-24 | -30.23 |